ConforMIS Reports 3Q16 Revenue
ConforMIS posted 3Q16 revenue of US $18.6MM, +34.1% vs. 3Q15. (Product revenue: U.S. $14.9MM, +43%; ex-U.S. $3.4MM, +14%) Growth is as reported.
Product sales breakdown per CFMS:
- iTotal CR, iUni and iDuo $14.4MM, +13.0%
- iTotal PS $4.0MM, +401% (full launch occurred in late 1Q16)
Double-digit growth in base business (iTotal CR and partial knees); base business new orders now exceed pre-recall levels
iTotal PS is becoming the primary product for new surgeon acquisition
Completed enrollment in >800 patient study comparing iTotal CR to leading off-the-shelf knees
Sources: ConforMIS, Inc.; ORTHOWORLD Inc.